Details for Patent: 8,124,799
✉ Email this page to a colleague
Which drugs does patent 8,124,799 protect, and when does it expire?
Patent 8,124,799 protects SKYCLARYS and is included in one NDA.
This patent has sixty patent family members in twenty-nine countries.
Summary for Patent: 8,124,799
Title: | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 |
Abstract: | This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: |
Inventor(s): | Anderson Eric, Jiang Xin, Visnick Melean |
Assignee: | Reata Pharmaceuticals, Inc. |
Application Number: | US12426778 |
Patent Claim Types: see list of patent claims | More… ↓ |
Drugs Protected by US Patent 8,124,799
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reata Pharms | SKYCLARYS | omaveloxolone | CAPSULE;ORAL | 216718-001 | Feb 28, 2023 | RX | Yes | Yes | 8,124,799 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,124,799
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 074895 | ⤷ Subscribe | |||
Australia | 2009237579 | ⤷ Subscribe | |||
Australia | 2009312820 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |